SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience

Business Deal Corporate Social

In vitro diagnostics company SD Biosensor and private equity investment firm SJL Partners announced on Tuesday that they have completed their acquisition of Cincinnati-based life science company Meridian Bioscience.

The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.

Under the terms of the agreement, Meridian shareholders will have the right to receive $34.00 per share in cash; Meridian stock will no longer be traded on Nasdaq.

Meridian develops, manufactures, and distributes diagnostic products and raw materials used in immunological and molecular tests for a broad range of applications.

Meridian will continue to operate independently under new ownership at its Cincinnati headquarters.

Page 1 of 11
Next Page